- Meeting abstract
- Open Access
Charcot osteoarthropathy in conservative treatment: clinical and functional results
© de Vasconcelos et al. 2015
- Published: 11 November 2015
- Medical Outcome Study
- Daily Task
- Walk Ability
- Progressive Degeneration
- Irreversible Deformation
Charcot neuro-osteoarthropathy (CA) is a rare complication of neuropathy that affects patients who have lost protective sensation, has multiple etiologies and diabetes mellitus is the most prevalent. The CA is progressive degeneration of the affected joints and it is known that, in situations where there is not an adequate intervention, can install the complete destruction of the affected joints, as well as irreversible deformations, which lead to the development of ulcers and high index of amputation. In the consolidation phase, surgical treatment is usually indicated; however, the procedure is not always possible due to clinical limitations of patients, or even surgical difficulty itself. The suropodalic orthosis adapted to the patient may present as an alternative therapy.
To describe sample of patients with Charcot osteoarthropathy Eichenholtz (E) III, Showm (S) C, followed in diabetic foot outpatient clinic of a tertiary hospital in conservative therapy using suropodalic orthosis, evaluating as the main question the walking ability and accomplishment of daily tasks, and the occurrence of ulcer and/or infection.
This is a prospective study, evaluated for the period of 5 years, 14 patients with CA, E III, SC, using suropodalic orthosis. Walking ability and accomplishment of daily tasks were routine annotated using as a tool of the domain 3 of the SF-36 (Medical Outcomes Study 36-Item Short-Form Health Survey), as well as occurrence of ulcer and/or infection.
Our data suggest that even in advanced stages of AC, when possible, the continued use of suropodalic orthosis may allow the maintenance function and walking ability.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.